You are here

Company Monitoring Page for Shire

latest headlines for company on cafepharma

Does a $50B-plus Shire buyout even make sense for Takeda? Maybe not

Endpoints

Wed, 03/28/18 - 07:16 pm

Tags:

Shire, Takeda, M&A

Drugmaker Shire soars as Japan's Takeda considers bid

CNBC

Wed, 03/28/18 - 10:13 am

Tags:

Shire, Takeda, M&A

Court Dismisses FTC’s Citizen Petition Complaint Against Shire

RAPS.org

Tue, 03/27/18 - 10:50 am

Tags:

FTC, citizen petitions, Shire, ViroPharma

12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you

Endpoints

Thu, 03/22/18 - 09:21 am

Tags:

drug launches, Hemlibra, Roche, Biktarvy, Gilead Sciences, Ozempic, Novo Nordisk, Erleada, JNJ, Shingrix, GSK, Patisiran, Alnylam, Sanofi, Epidiolex, GW Pharma, Aimovig, Amgen, Novartis, lanadelumab, Shire, Elagolix, AbbVie, Steglatro, Pfizer, Merck, Sublocade, Indivior

Shire CEO sees Microsoft tie-up building momentum for faster rare disease diagnosis

Fierce Pharma

Wed, 03/21/18 - 11:28 pm

Tags:

Shire, Pharma CEOs, Microsoft, rare disease, Flemming Ornskov

Ocugen’s Dry Eye Disease Therapy Could Compete with Allergan and Shire

Xtalks

Wed, 03/21/18 - 10:55 am

Tags:

Ocugen, dry eye disease, OCU310, Shire, Allergan, Restasis, Xiidra

Top 5 boards for week ending March 10, 2018

CP Wire

Sun, 03/11/18 - 03:05 pm

Tags:

Daiichi Sankyo, Shire, Amgen, Sanofi, AstraZeneca

Shire's HAE candidate boosted by new Phase 3 data

Biopharma Dive

Tue, 03/6/18 - 09:31 am

Tags:

Shire, HAE, clinical trials, lanadelumab

Top 5 viewed boards for week ending March 3, 2018

CP Wire

Sun, 03/4/18 - 01:50 pm

Tags:

cafepharma, Daiichi Sankyo, Shire, Allergan, Amgen, Sanofi, sales meeting, layoffs, Esmya, Pfizer, Celgene, M&A

Analyzing the orphan drugs market ($127bn)

GoinPharma

Fri, 03/2/18 - 09:48 am

Tags:

orphan drugs, Shire, Baxalta, Sanofi, Bioverativ, M&A

Why big pharma companies always create new spinoffs

GoinPharma

Sun, 01/28/18 - 10:06 am

Tags:

spinoffs, Sanofi, Celgene, Biogen, AbbVie, Abbott Labs, Baxalta, Shire

Shire set for in-house production of rare disease drug Cinryze after shortage issues

Fierce Pharma

Thu, 01/25/18 - 12:00 am

Tags:

Shire, Cinryze, drug shortages, HAE, drug manufacturing

Shire's latest approval won't save it from Hemlibra

Biopharma Dive

Wed, 01/17/18 - 09:58 pm

Tags:

Shire, Hemlibra, Adynovi, hemophilia, Europe, Adynovate

Shire CEO Flemming Ornskov is hatching a few new stretch goals for R&D in 2018 — and beyond

Endpoints

Fri, 01/12/18 - 10:36 am

Tags:

Shire, Pharma CEOs, Flemming Ornskov, R&D

JPM18: Shire holds onto neuroscience unit, for now

Biopharma Dive

Mon, 01/8/18 - 10:04 pm

Tags:

Shire, JPMHC 2018, Neurosciences

Shire creates separate neurosciences division for future investments; Agenus gains $28M in royalty deal

Endpoints

Mon, 01/8/18 - 11:26 am

Tags:

Shire, ADHD, Neurosciences

Shire seeks FDA sign-off on plasma manufacturing facility

Biopharma Dive

Sat, 01/6/18 - 12:28 pm

Tags:

Shire, FDA, drug manufacturing, plasma, Gammagard

Shire hit by a setback as Hunter syndrome drug fails late-stage study

Endpoints

Tue, 12/19/17 - 12:04 pm

Tags:

Shire, Hunter Syndrome, clinical trials, SHP609, Elaprase

Shire looks to stall Hemlibra impact with court injunction

BioPharma Dive

Tue, 12/19/17 - 12:03 pm

Tags:

Shire, Hemlibra, Roche, hemophilia

The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate

Endpoints

Sun, 12/17/17 - 11:47 am

Pages

last 30 twitter posts